Johnson & Johnson sued to stop the U.S. government from empowering Health and Human Services (HHS) to negotiate lower drug prices for Medicare recipients. The major drugmaker became the third player in the industry attempting to halt the Medicare drug-price negotiations established by the Inflation Reduction Act (IRA), in a claim filed in the U.S. District…

The European Union’s medicines regulator said on Tuesday that there is a “possible link” between Johnson & Johnson’s COVID-19 vaccine and blood clots, but said its “overall benefit-risk remains positive.” At a meeting on Tuesday, the safety committee of the European Medicines Agency (EMA) concluded that a warning about unusual blood clots should be added…

Clinical trials showing the single-shot Janssen vaccine as being 66 percent effective at preventing the COVID-19 disease are “very encouraging,” British Prime Minister Boris Johnson said on Friday. “We have secured 30 million doses, and if approved by our medicines regulator we should expect these to be available later this year,” he wrote on Twitter. Janssen…